Nanocrystals of a potent p38 MAPK inhibitor embedded in microparticles: Therapeutic effects in inflammatory and mechanistic murine models of osteoarthritis

Uloženo v:
Podrobná bibliografie
Název: Nanocrystals of a potent p38 MAPK inhibitor embedded in microparticles: Therapeutic effects in inflammatory and mechanistic murine models of osteoarthritis
Autoři: Maudens, Pierre Marc Xavier, Seemayer, Christian Alexander, Pfefferlé, François, Jordan, Olivier, Allémann, Eric
Zdroj: Journal of Controlled Release, Vol. 276 (2018) pp. 102-112
Informace o vydavateli: Elsevier BV, 2018.
Rok vydání: 2018
Témata: Male, 0301 basic medicine, Benzamides/administration & dosage/chemistry, Pyridones, p38 Mitogen-Activated Protein Kinases, 03 medical and health sciences, Osteoarthritis, Osteoarthritis/drug therapy, Animals, Humans, Protein Kinase Inhibitors/administration & dosage/chemistry, Protein Kinase Inhibitors, ddc:615, 0303 health sciences, Anti-Inflammatory Agents, Non-Steroidal, Pyridones/administration & dosage/chemistry, Mice, Inbred C57BL, Disease Models, Animal, Drug Liberation, Anti-Inflammatory Agents, Non-Steroidal/administration & dosage/chemistry, Delayed-Action Preparations/administration & dosage/chemistry, Nanoparticles/administration & dosage/chemistry, Delayed-Action Preparations, Benzamides, Nanoparticles, p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors
Popis: This study aimed to formulate nanocrystal-polymer particles (NPPs) containing the potent p38α/β MAPK inhibitor PH-797804 (PH-NPPs) and to test their extended-release properties over months in comparison to those of conventional PH microparticles for the intra-articular treatment of inflammatory and mechanistic murine models mirroring aspects of human osteoarthritis (OA). The steps of the study were (i) to formulate PH nanocrystals (wet milling), (ii) to encapsulate a high payload of PH nanocrystals in fluorescent particles (spray drying), (iii) to assess in vitro drug release, (iv) to evaluate PH-NPP toxicity to human OA synoviocytes (MTT test), (v) to investigate the in vivo bioactivity of the particles in mice in an inflammatory antigen-induced arthritis (AIA) model (using histology and RT-qPCR) and (vi) to investigate the in vivo bioactivity of the particles in the OA model obtained by mechanistic surgical destabilization of the medial meniscus (DMM) (using histology, micro-CT, and multiplex ELISA). The PH nanocrystals stabilized with vitamin E TPGS had a monomodal size distribution. The PH-NPPs had a mean diameter of 14.2 μm and drug loading of ~31.5% (w/w), and ~20% of the PH was released over 3 months. The NPPs did not exhibit toxicity to cultured human OA synoviocytes at 100 × IC50. Finally, in vivo studies showed good retention of PH-NPPs in the joint and adjacent tissues for up to 2 months, and the PH-NPPs exhibited good functional relevance by significantly reducing inflammation and joint destruction and by inhibiting several biomarkers (e.g., IL-1β). In conclusion, local treatment with PH-NPPs, used as an extended-release drug delivery system, improved inflammation and joint degradation in two distinct mouse models, indicating treatment potential for human OA.
Druh dokumentu: Article
Popis souboru: application/pdf
Jazyk: English
ISSN: 0168-3659
DOI: 10.1016/j.jconrel.2018.03.007
Přístupová URL adresa: https://archive-ouverte.unige.ch/unige:141549/ATTACHMENT01
https://pubmed.ncbi.nlm.nih.gov/29524442
https://www.ncbi.nlm.nih.gov/pubmed/29524442
https://www.sciencedirect.com/science/article/pii/S0168365918301299
https://archive-ouverte.unige.ch/unige:141549
http://europepmc.org/abstract/MED/29524442
https://pubmed.ncbi.nlm.nih.gov/29524442/
https://archive-ouverte.unige.ch/unige:141549/ATTACHMENT01
https://archive-ouverte.unige.ch/unige:141549
https://archive-ouverte.unige.ch/unige:141549
https://doi.org/10.1016/j.jconrel.2018.03.007
Rights: Elsevier TDM
CC BY NC ND
Přístupové číslo: edsair.doi.dedup.....dd923cfc3df1e7e5e0b9a10c1e9b7bbf
Databáze: OpenAIRE
Popis
Abstrakt:This study aimed to formulate nanocrystal-polymer particles (NPPs) containing the potent p38α/β MAPK inhibitor PH-797804 (PH-NPPs) and to test their extended-release properties over months in comparison to those of conventional PH microparticles for the intra-articular treatment of inflammatory and mechanistic murine models mirroring aspects of human osteoarthritis (OA). The steps of the study were (i) to formulate PH nanocrystals (wet milling), (ii) to encapsulate a high payload of PH nanocrystals in fluorescent particles (spray drying), (iii) to assess in vitro drug release, (iv) to evaluate PH-NPP toxicity to human OA synoviocytes (MTT test), (v) to investigate the in vivo bioactivity of the particles in mice in an inflammatory antigen-induced arthritis (AIA) model (using histology and RT-qPCR) and (vi) to investigate the in vivo bioactivity of the particles in the OA model obtained by mechanistic surgical destabilization of the medial meniscus (DMM) (using histology, micro-CT, and multiplex ELISA). The PH nanocrystals stabilized with vitamin E TPGS had a monomodal size distribution. The PH-NPPs had a mean diameter of 14.2 μm and drug loading of ~31.5% (w/w), and ~20% of the PH was released over 3 months. The NPPs did not exhibit toxicity to cultured human OA synoviocytes at 100 × IC50. Finally, in vivo studies showed good retention of PH-NPPs in the joint and adjacent tissues for up to 2 months, and the PH-NPPs exhibited good functional relevance by significantly reducing inflammation and joint destruction and by inhibiting several biomarkers (e.g., IL-1β). In conclusion, local treatment with PH-NPPs, used as an extended-release drug delivery system, improved inflammation and joint degradation in two distinct mouse models, indicating treatment potential for human OA.
ISSN:01683659
DOI:10.1016/j.jconrel.2018.03.007